| Company Name: |
Guangzhou Isun Pharmaceutical Co., Ltd
|
| Tel: |
020-39119399 18927568969 |
| Email: |
isunpharm@qq.com |
| Products Intro: |
Product Name:4-[2-[4-[3-(4-Chlorophenyl)-2-propenyl]-1-piperazinyl]ethyl]benzoic acid sulfate
CAS:86621-94-5
Purity:>=98% (HPLC), powder Package:25Mg; 1g; 100g; 500g
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:BM 15766 sulfate
CAS:86621-94-5
Purity:>=98% (HPLC), powder Package:5MG Remarks:B8685-5MG
|
| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:BM 15.766
CAS:86621-94-5
Purity:>=98% Package:50mg Remarks:S53457
|
BM 15.766 manufacturers
- BM 15766 sulfate
-
- $0.00 / 50mg
-
2024-11-19
- CAS:86621-94-5
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | BM 15.766 Basic information |
| Product Name: | BM 15.766 | | Synonyms: | Benzoic acid, 4-[2-[4-[3-(4-chlorophenyl)-2-propenyl]-1-piperazinyl]ethyl]-, sulfate (1:1) (9CI);4-(2-(4-(3-(4-chlorophenyl)allyl)piperazin-1-yl)ethyl)benzoic acid sulfate;BM 15.766;BM 15766 sulfate >=98% (HPLC), powder | | CAS: | 86621-94-5 | | MF: | C22H27ClN2O6S | | MW: | 482.98 | | EINECS: | | | Product Categories: | | | Mol File: | 86621-94-5.mol |  |
| | BM 15.766 Chemical Properties |
| Melting point | >300 °C | | storage temp. | 2-8°C | | solubility | DMSO: soluble 4mg/mL
water: insoluble | | form | powder | | color | white |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 |
| | BM 15.766 Usage And Synthesis |
| Uses | BM 15766 sulfate is an inhibitor of 7-dehydrocholesterol δ7-reductase and reduces plasma cholesterol levels. BM 15766 sulfate is a hypolipidemic agent[1][2]. | | Biochem/physiol Actions | Dehydrocholesterol reductase inhibitor. Inhibits 7-dehydrocholesterol reductase, which catalyzes the last step of cholesterol synthesis. | | References | [1] Baumgart E, et al. Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation. FEBS Lett. 1990 May 7;264(1):5-9. DOI:10.1016/0014-5793(90)80750-d
[2] Honda, et al. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations. Hepatology. 1996 Aug;24(2):435-9. DOI:10.1002/hep.510240223 |
| | BM 15.766 Preparation Products And Raw materials |
|